Abstract:Inoculation routes may significantly affect vaccine performance due to the local microenvironment, antigen localization and presentation, and, therefore, final immune responses. In this study, we conducted a head-to-head comparison of immune response and safety of inactivated rabies vaccine inoculated via intraperitoneal (IP), intramuscular (IM), subcutaneous (SC) and needle-free injection technology-based intradermal (ID) routes in ICR mice. Immune response was assessed in terms of antigen-specific antibodies, antibody subtypes and neutralizing antibodies for up to 28 weeks. A live rabies virus challenge was also carried out to evaluate vaccine potency. The dynamics of inflammatory cell infiltration at the skin and muscle levels were determined via histopathological examination. The kinetics and distribution of a model antigen were also determined by using in vivo fluorescence imaging. Evidence is presented that the vaccine inoculated via the ID route resulted in the highest antigen-specific antibody and neutralizing antibody titers among all administration routes, while IP and IM routes were comparable, followed by the SC route. Antibody subtype analysis shows that the IP route elicited a Th1-biased immune response, while SC and IM administration elicited a prominent Th2-type immune response. Unexpectedly, the ID route leads to a balanced Th1 and Th2 immune response. In addition, the ID route conferred effective protection against lethal challenge with 40 LD50 of the rabies CVS strain, which was followed by IP and IM routes. Moreover, a one-third dose of the vaccine inoculated via the ID route provided comparable or higher efficacy to a full dose of the vaccine via the other three routes. The superior performance of ID inoculation over other routes is related to longer local retention at injection sites and higher lymphatic drainage. Histopathology examination reveals a transient inflammatory cell infiltration at ID and IM injection sites which peaked at 48 h and 24 h, respectively, after immunization, with all side effects disappearing within one week. These results suggest that needle-free injection technology-based ID inoculation is a promising strategy for rabies vaccination in regard to safety and efficacy.

Ptosis Caused by Local Injection of Human Rabies Immunoglobulin

Survival of 21 Dogs after Post-exposure Prophylaxis using Intra-dermal Rabies Vaccine in the Pre-scapular Region and Emergency Use of Expired Equine Rabies Immunoglobulin for Local Wound Infiltration in Victims of a Rabid Dog Bite using One Health Approach

Serum Sickness like Reaction Postequine Rabies Immunoglobulins

Modern biologics for rabies prophylaxis and the elimination of human cases mediated by dogs

Severe multiple rabid dog bite injuries in a child in central China: Continuous 10-year observation and analysis on this case

Expert consensus on the clinical application of ormutivimab injection for use against the rabies virus

Efficacy of ormutivimab, a novel recombinant human anti-rabies monoclonal antibody, in post-exposure prophylaxis animal models

Development of Human Monoclonal Antibodies With Broad Reactivity for Rabies Postexposure Prophylaxis

Preexposure and Postexposure Prophylaxis of Rabies With Adeno-Associated Virus Expressing Virus-Neutralizing Antibody in Rodent Models

Rabies Virus Infection Causes Pyroptosis of Neuronal Cells

Occurrence of Rabies in Post Exposure Vaccinated Cattle with Dog Bite Injury above the Neck Region

Post-exposure Treatment with Anti-rabies VHH and Vaccine Significantly Improves Protection of Mice from Lethal Rabies Infection

Rabbit Anti-Rabies Immunoglobulins Production and Evaluation

Potential Option for Rabies Post-Exposure Prophylaxis: New Vaccine with PIKA Adjuvant Against Diverse Chinese Rabies Strains.

Probable paralytic rabies in a dog: ante-mortem clinical diagnosis implications in limited resource settings

Epidemiological Characteristics And Rabies Post-Exposure Prophylaxis Status Of 5497 Patients With Bite Injuries Of Beijing, China

Immune Response of Inactivated Rabies Vaccine Inoculated via Intraperitoneal, Intramuscular, Subcutaneous and Needle-Free Injection Technology-Based Intradermal Routes in Mice

Characterization Of A Human Antibody Fragment Fab And Its Calcium Phosphate Nanoparticles That Inhibit Rabies Virus Infection With Vaccine

Immunogenicity of 4-dose Essen intramuscular regimen for rabies post-exposure prophylaxis: A multi-center cross-sectional study in China

A Retrospective Descriptive Analysis of Rabies Post-Exposure Prophylaxis Cases in Dalian from 2016 to 2017.

Fatal cases in pediatric patients after post-exposure prophylaxis for rabies: A report of two cases